New drug pricing plans will ‘damage UK biotech’
August 16, 2013Research and Development, Sales and Marketing BIA, Hunt, NHS, VBP, bates, biotech
The BioIndustry Association is warning that the government’s new drug pricing scheme could put future investment in the UK’s biotech …
Boehringer to shut down Petersburg chemicals facility
August 16, 2013Manufacturing and Production, Sales and Marketing Boehringer, Petersburg
Boehringer Ingelheim has conceded defeat in its search for a buyer for its chemicals facility in Petersburg, US, and is …
Price cut not enough for Pfizer’s Xalkori
August 16, 2013Sales and Marketing NICE, Pfizer, Xalkori, lung cancer
In final draft guidance NICE has rejected Pfizer’s new lung cancer drug Xalkori because of its high cost. The Institute …
Pharmstandard buys Singapore API firm to guarantee supply
August 16, 2013Manufacturing and Production OTC, Pharmstandard, bever
Russia’s largest drug company Pharmstandard has agreed a $590 million deal to buy the Singapore-based supplier of active pharmaceutical ingredients …
Cadence appoints Laureen DeBuono to its Board
August 16, 2013Manufacturing and Production, Medical Communications, Research and Development DeBuono, cadence
Biopharma firm Cadence Pharmaceuticals has appointed Laureen DeBuono to its Board of directors. “We are very pleased to welcome Ms …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
